Clinical Trials in Austin

Showing 2881-2900 of 7,312 trials

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

NCT04623996

This study will evaluate preliminary safety and efficacy of TP-0184 to treat anemia when administered to adult patients with Revised International Prognostic Scoring System (IPSS-R) low or intermediate risk MDS. The recommended Phase 2 dose (RP2D) will be determined by the maximum tolerated dose (MTD) or maximum administered dose (MAD) in the Phase 1 portion of the study.

Anemia in Myelodysplastic Syndromes

Sumitomo Pharma America, Inc.2 participantsStarted Dec 2020

Plantation, Florida, United States • The Bronx, New York, United States • Austin, Texas, United States

TERMINATEDPhase 2< 1 mile

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

NCT05253755

The purpose for this study is to assess the Safety and Efficacy of Daily Application for 4 weeks of DBI-001 Gel Versus Aqueous Gel in Subjects with Atopic Dermatitis

Atopic Dermatitis

DermBiont, Inc.10 participantsStarted Oct 2021

Scottsdale, Arizona, United States • Austin, Texas, United States • Mill Creek, Washington, United States

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

NCT04688671

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy and Safety of ETX 018810 in Subjects with Diabetic Peripheral Neuropathic Pain.

Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathy

Eliem Therapeutics (UK) Ltd.167 participantsStarted Nov 2020

Mobile, Alabama, United States • Phoenix, Arizona, United States • Fresno, California, United States +19 more locations

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

Find Trials by Condition in Austin

A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

BD MiniDraw™ Capillary System Clinical Equivalence Study

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Increased Protein at Breakfast for Weight Management in Overweight Adolescents

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis

Open-label Extension Study of Brazikumab in Ulcerative Colitis

Efficacy and Safety of Sirolimus in LAM

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

A Device Study for the Treatment of Acne